Boston Scientific Wins Farapluse Approval in China

MassDevice24minutes ago

If You Invested $1000 In This Stock 10 Years Ago, You Would Have $5,900 Today

Boston Scientific (NYSE:BSX) has outperformed the market over the past 10 years by 8.59% on an annualized basis producing an average annual return of 19.49%. Currently, Boston Scientific has a market

BenzingaJul 8 23:00

Pulse Stock Rallies 22% on FDA Breakthrough Designation

Seeking AlphaJul 8 22:41

Global Deep Brain Stimulation Market Report 2024-2029 - Boston Scientific, Medtronic and Abbott Continue Their Market Dominance - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Global Deep Brain Stimulation Market: Analysis by Product, Application, End Use, Region Size, Trends and Forecast up to 2029" report has been added to ResearchAndMarkets.

BusinesswireJul 8 20:07

Boston Scientific to Present Key Data at the 2024 American Society of Pain & Neuroscience Conference

MARLBOROUGH, Mass., July 8, 2024 -- Boston Scientific Corporation (NYSE: BSX) today announced the company's clinical data will be featured at the sixth annual American Society of Pain & Neuroscience (

Boston ScientificJul 8 12:00

Artisan Global Discovery Fund Trimmed Boston Scientific Corporation (BSX) for Valuation Discipline

Yahoo FinanceJul 3 22:45